SEC Form 4 · accession 0001209191-18-014949
Conatus Pharmaceuticals Inc. · CNAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alfred P. Spada
Officer — EVP, R&D and CSO
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001383701
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2018 | M | 12,121 | $1.24 | A | 12,121 | D | |
| Common StockF1 | holding | — | — | — | 247,142 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.24 | Feb 27, 2018 | M | 12,121 | D | Mar 3, 2008 | Mar 2, 2018 | Common Stock | 12,121 | 0 | D |
Explanation of responses
- F1Held by a family trust of which Dr. Spada is a trustee.